Balance Sheet

Current Liabilities	53.1m
Accounts Payable	17.2m
Accrued Liabilities	32.4m
Other Current Liabilities	3.5m
Non-Current Liabilities	144.1m
Long-Term Debt	130.8m
Other Non-Current Liabilities	13.2m

Currency: USD

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	17	10	10	43	23	27	56	51	87	51
Cash Equivalents	17	10	10	43	23	27	56	51	87	51
Short-Term Investments	5	6	5	0	0	0	0	0	0	0
Total Receivables	0	1	1	4	1	4	13	29	16	27
Accounts Receivables	0	1	1	4	1	4	13	29	16	27
Other Receivables	0	0	0	0	0	0	0	0	0	0
Inventory	2	3	5	13	19	53	82	125	163	173
Other Current Assets	0	0	0	3	2	3	3	4	5	5
Total Current Assets	24	21	22	62	45	86	154	209	270	257
PP&E Net	3	2	2	31	30	33	46	58	69	63
PP&E Gross	0	2	2	31	30	33	46	58	69	63
Accumulated Depreciation	0	2	2	1	3	6	9	13	20	27
Intangible Assets	0	0	0	5	4	3	2	2	1	0
Goodwill	0	0	0	4	4	4	4	4	4	4
Other Long-Term Assets	0	0	0	7	7	1	2	4	5	5
Other Assets	0	0	0	4	4	4	4	4	4	4
Total Assets	27 N/A	24 -12%	24 N/A	108 +356%	89 -18%	127 +43%	208 +63%	276 +33%	349 +26%	329 -6%
Liabilities
Accounts Payable	2	2	3	6	6	9	11	12	13	16
Accrued Liabilities	2	2	2	3	4	5	9	17	24	31
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	6	0	0	0	0	0	0	0
Other Current Liabilities	0	0	0	0	0	0	0	1	2	3
Total Current Liabilities	4	4	11	9	10	14	20	30	39	50
Long-Term Debt	15	16	14	43	44	83	93	95	143	131
Other Liabilities	2	3	3	15	15	4	7	10	14	14
Total Liabilities	21 N/A	23 +9%	28 +23%	68 +141%	69 +2%	101 +46%	119 +18%	135 +13%	197 +45%	194 -1%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	69	87	107	151	216	265	341	412	478	506
Additional Paid In Capital	76	88	103	191	236	291	429	553	630	641
Total Equity	6 N/A	1 -87%	5 N/A	40 N/A	20 -51%	26 +32%	88 +237%	141 +60%	152 +8%	135 -11%
Total Liabilities & Equity	27 N/A	24 -12%	24 N/A	108 +356%	89 -18%	127 +43%	208 +63%	276 +33%	349 +26%	329 -6%
Shares Outstanding
Common Shares Outstanding	9	11	13	37	46	59	105	196	222	226

ADMA Biologics Inc
NASDAQ:ADMA